Thus the regulation of Nrf2 may be key to the management of the so-called ‘diseases of aging’, which include cardiovascular disease, neurodegenerative diseases, cancer, type 2 diabetes, chronic failure of the kidneys and heart and COPD [14], [28]. This evidence concerns the gene NFE2L2 and neurodegenerative disease.